CARILLON TOWER ADVISERS, INC. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$3,992,000
+21.6%
158,677
+0.8%
0.02%
-45.5%
Q3 2020$3,282,000
+1.1%
157,477
+15.2%
0.04%
+76.0%
Q2 2020$3,247,000
-99.9%
136,735
-2.7%
0.02%0.0%
Q1 2020$2,528,000,000
-30.9%
140,535
-8.8%
0.02%
+4.2%
Q4 2019$3,656,000,000
+39039.3%
154,135
-54.7%
0.02%
-63.1%
Q3 2019$9,341,000
-33.8%
339,910
-20.2%
0.06%
-33.0%
Q2 2019$14,103,000
-28.4%
426,210
-24.2%
0.10%
-30.2%
Q1 2019$19,705,000
-4.7%
562,360
-9.7%
0.14%
-20.6%
Q4 2018$20,678,000
+5.5%
622,460
+59.9%
0.18%
+24.1%
Q3 2018$19,603,000
-25.1%
389,335
-11.0%
0.14%
-31.6%
Q2 2018$26,184,000
+237.4%
437,500
+158.2%
0.21%
+243.3%
Q1 2018$7,761,000169,4750.06%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders